Study	Design	Hip Fracture	Blood Loss	Blood Transfusion	Adverse Events
Watts et al. 2017	RCT with 138 patients	Arthroplasty for femoral neck fracture	Reduced by 305 mL in TXA group (p=0.0005)	Reduced by 9% in TXA group (p=0.22)	No increased risk with TXA
Drakos et al. 2017	RCT with 200 patients	IT fracture treated with DHS or CMN	Reduced HCT loss by 2.5 in TXA group (p<0.01)	Reduced by 43% in TXA group (p<0.01)	No increased risk with TXA
Virani et al. 2016	RCT with 137 patients	IT fracture treated with CMN	No significant difference in blood loss	No significant difference in transfusion rate	No increased risk with TXA
Schiavone et al. 2018	RCT with 90 patients	IT fracture treated with CMN	n/a	Reduced by 18% in TXA group (p<0.05)	No increased risk with TXA
Tengberg et al. 2016	RCT with 72 patients	IT fracture treated with CMN	Reduced by 570 mL in TXA group (p=0.029)	Reduced by 0.6% in TXA group (p=0.21)	No increased risk with TXA
Barauh et al. 2016	RCT with 60 patients	IT fracture treated with DHS	Reduced by 270 mL in TXA group (p<0.001)	n/a	No increased risk with TXA
Lee at al. 2015	Retrospective cohort study of 271 patients	Hemiarthroplasty for femoral neck fractures	Reduced drop in hemoglobin (<2g/dl) in TXA group (p=0.014)	Reduced by 13% in TXA group (p=0.005)	No increased risk with TXA
Mohib et al. 2015	RCT with 100 patients	IT fractures treated with DHS or CMN	Reduced hemoglobin loss by 1.3 g/dl in TXA group (p=0.007)	Reduced by 24% in TXA group (p=0.009)	No increased risk with TXA